Literature DB >> 19301871

Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods.

Vojtech Klusák1, Cyril Barinka, Anna Plechanovová, Petra Mlcochová, Jan Konvalinka, Lubomír Rulísek, Jacek Lubkowski.   

Abstract

Glutamate carboxypeptidase II (GCPII, EC 3.4.17.21) is a zinc-dependent exopeptidase and an important therapeutic target for neurodegeneration and prostate cancer. The hydrolysis of N-acetyl-l-aspartyl-l-glutamate (N-Ac-Asp-Glu), the natural dipeptidic substrate of the GCPII, is intimately involved in cellular signaling within the mammalian nervous system, but the exact mechanism of this reaction has not yet been determined. To investigate peptide hydrolysis by GCPII in detail, we constructed a mutant of human GCPII [GCPII(E424A)], in which Glu424, a putative proton shuttle residue, is substituted with alanine. Kinetic analysis of GCPII(E424A) using N-Ac-Asp-Glu as substrate revealed a complete loss of catalytic activity, suggesting the direct involvement of Glu424 in peptide hydrolysis. Additionally, we determined the crystal structure of GCPII(E424A) in complex with N-Ac-Asp-Glu at 1.70 A resolution. The presence of the intact substrate in the GCPII(E424A) binding cavity substantiates our kinetic data and allows a detailed analysis of GCPII/N-Ac-Asp-Glu interactions. The experimental data are complemented by the combined quantum mechanics/molecular mechanics calculations (QM/MM) which enabled us to characterize the transition states, including the associated reaction barriers, and provided detailed information concerning the GCPII reaction mechanism. The best estimate of the reaction barrier was calculated to be DeltaG(++) approximately 22(+/-5) kcal x mol(-1), which is in a good agreement with the experimentally observed reaction rate constant (k(cat) approximately 1 s(-1)). Combined together, our results provide a detailed and consistent picture of the reaction mechanism of this highly interesting enzyme at the atomic level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301871      PMCID: PMC7289149          DOI: 10.1021/bi900220s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  Generalized Gradient Approximation Made Simple.

Authors: 
Journal:  Phys Rev Lett       Date:  1996-10-28       Impact factor: 9.161

2.  The high-resolution structures of the neutral and the low pH crystals of aminopeptidase from Aeromonas proteolytica.

Authors:  William Desmarais; David L Bienvenue; Krzysztof P Bzymek; Gregory A Petsko; Dagmar Ringe; Richard C Holz
Journal:  J Biol Inorg Chem       Date:  2006-04-05       Impact factor: 3.358

3.  The coordination of the catalytic zinc in alcohol dehydrogenase studied by combined quantum-chemical and molecular mechanics calculations.

Authors:  U Ryde
Journal:  J Comput Aided Mol Des       Date:  1996-04       Impact factor: 3.686

4.  Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II.

Authors:  Cyril Barinka; Markéta Rinnová; Pavel Sácha; Camilo Rojas; Pavel Majer; Barbara S Slusher; Jan Konvalinka
Journal:  J Neurochem       Date:  2002-02       Impact factor: 5.372

5.  Interactions of Streptomyces griseus aminopeptidase with a methionine product analogue: a structural study at 1.53 A resolution.

Authors:  R Gilboa; H M Greenblatt; M Perach; A Spungin-Bialik; U Lessel; G Wohlfahrt; D Schomburg; S Blumberg; G Shoham
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-05

Review 6.  Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers.

Authors:  M C Gong; S S Chang; M Sadelain; N H Bander; W D Heston
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

7.  Expression of glutamate carboxypeptidase II in human brain.

Authors:  P Sácha; J Zámecník; C Barinka; K Hlouchová; A Vícha; P Mlcochová; I Hilgert; T Eckschlager; J Konvalinka
Journal:  Neuroscience       Date:  2006-12-05       Impact factor: 3.590

Review 8.  The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases.

Authors:  Bénédicte Cauwe; Philippe E Van den Steen; Ghislain Opdenakker
Journal:  Crit Rev Biochem Mol Biol       Date:  2007 May-Jun       Impact factor: 8.250

9.  Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases.

Authors:  A F Monzingo; B W Matthews
Journal:  Biochemistry       Date:  1984-11-20       Impact factor: 3.162

10.  Expression of prostate-specific membrane antigen in normal and malignant human tissues.

Authors:  Yoshihisa Kinoshita; Katsuyuki Kuratsukuri; Steve Landas; Katsumi Imaida; Peter M Rovito; Ching Y Wang; Gabriel P Haas
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

View more
  20 in total

1.  A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.

Authors:  Andrew X Zhang; Ryan P Murelli; Cyril Barinka; Julien Michel; Alexandra Cocleaza; William L Jorgensen; Jacek Lubkowski; David A Spiegel
Journal:  J Am Chem Soc       Date:  2010-09-15       Impact factor: 15.419

Review 2.  Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.

Authors:  C Bařinka; C Rojas; B Slusher; M Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  The Small Molecule Hyperphyllin Enhances Leaf Formation Rate and Mimics Shoot Meristem Integrity Defects Associated with AMP1 Deficiency.

Authors:  Olena Poretska; Saiqi Yang; Delphine Pitorre; Wilfried Rozhon; Karin Zwerger; Marcos Castellanos Uribe; Sean May; Peter McCourt; Brigitte Poppenberger; Tobias Sieberer
Journal:  Plant Physiol       Date:  2016-05-03       Impact factor: 8.340

4.  Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II.

Authors:  Michal Navrátil; Jakub Ptáček; Pavel Šácha; Jana Starková; Jacek Lubkowski; Cyril Bařinka; Jan Konvalinka
Journal:  FEBS J       Date:  2014-06-17       Impact factor: 5.542

5.  Molecular modeling approach to predict a binding mode for the complex methotrexate-carboxypeptidase G2.

Authors:  Kely Medeiros Turra; Kerly Fernanda Mesquita Pasqualoto; Elizabeth Igne Ferreira; Daniela Gonçales Rando
Journal:  J Mol Model       Date:  2011-08-25       Impact factor: 1.810

6.  Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.

Authors:  Anna Plechanovová; Youngjoo Byun; Glenda Alquicer; L'ubica Skultétyová; Petra Mlčochová; Adriana Němcová; Hyung-Joon Kim; Michal Navrátil; Ronnie Mease; Jacek Lubkowski; Martin Pomper; Jan Konvalinka; Lubomír Rulíšek; Cyril Bařinka
Journal:  J Med Chem       Date:  2011-10-11       Impact factor: 7.446

7.  Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme.

Authors:  Jesse Alt; Marigo Stathis; Camilo Rojas; Barbara Slusher
Journal:  FASEB J       Date:  2013-03-23       Impact factor: 5.191

8.  Structural and biochemical characterization of a novel aminopeptidase from human intestine.

Authors:  Jan Tykvart; Cyril Bařinka; Michal Svoboda; Václav Navrátil; Radko Souček; Martin Hubálek; Martin Hradilek; Pavel Šácha; Jacek Lubkowski; Jan Konvalinka
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

9.  Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.

Authors:  Haofan Wang; Youngjoo Byun; Cyril Barinka; Mrudula Pullambhatla; Hyo-Eun C Bhang; James J Fox; Jacek Lubkowski; Ronnie C Mease; Martin G Pomper
Journal:  Bioorg Med Chem Lett       Date:  2009-10-24       Impact factor: 2.823

10.  Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II.

Authors:  Jiri Pavlicek; Jakub Ptacek; Jiri Cerny; Youngjoo Byun; Lubica Skultetyova; Martin G Pomper; Jacek Lubkowski; Cyril Barinka
Journal:  Bioorg Med Chem Lett       Date:  2014-03-28       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.